Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,639 Cr
up ₹125 Cr vs Jun 2026
- Stocks held
- 29
- up 1 vs Jun 2026
- Top 10 weight
- 61.2%
- of the portfolio in its ten largest
- Cash & debt
- 6.7%
- cash, money market and debt
- Moves this month
- 3 in · 2 out
- added to 10, trimmed 10
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In July 2026 it disclosed 29 stocks worth ₹3,639 Cr, up ₹125 Cr from Jun 2026. Its largest positions were Sun Pharmaceutical Industries Limited (8.4%), IPCA Laboratories Limited (8.1%), Cipla Limited (8.1%); the ten largest together made up 61.2% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 66.4% of its equity. Cash and debt stood at 6.7%. Compared with Jun 2026 the fund entered 3 new stocks and exited 2.
Against 226 other Sectoral / Thematic funds
Concentration
85%
Top-10 weight is higher than 85% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
85%
Holds more cash than 85% of peers
Holdings in July 2026
Download CSVEvery line the fund disclosed, with the change against Jun 2026. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 8.40%
- Δ weight
- up 0.26 pts
- Value
- ₹306 Cr
- Δ value
- up ₹19.7 Cr
- Status
- Added
- Weight
- 8.15%
- Δ weight
- down 0.06 pts
- Value
- ₹296 Cr
- Δ value
- up ₹7.9 Cr
- Status
- Added
- Weight
- 8.10%
- Δ weight
- down 0.24 pts
- Value
- ₹295 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Weight
- 7.07%
- Δ weight
- up 0.20 pts
- Value
- ₹257 Cr
- Δ value
- up ₹15.8 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 6.73%
- Δ weight
- down 0.04 pts
- Value
- ₹245 Cr
- Δ value
- up ₹6.9 Cr
- Status
- Added
- Weight
- 6.33%
- Δ weight
- down 0.21 pts
- Value
- ₹230 Cr
- Δ value
- up ₹73 L
- Status
- Held
- Weight
- 5.79%
- Δ weight
- up 0.98 pts
- Value
- ₹211 Cr
- Δ value
- up ₹41.8 Cr
- Status
- Added
- Weight
- 5.55%
- Δ weight
- down 0.17 pts
- Value
- ₹202 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 4.64%
- Δ weight
- up 2.03 pts
- Value
- ₹169 Cr
- Δ value
- up ₹77.2 Cr
- Status
- Added
- Weight
- 3.74%
- Δ weight
- down 0.39 pts
- Value
- ₹136 Cr
- Δ value
- down ₹8.9 Cr
- Status
- Trimmed
- Weight
- 3.46%
- Δ weight
- down 0.15 pts
- Value
- ₹126 Cr
- Δ value
- down ₹77 L
- Status
- Trimmed
- Weight
- 3.16%
- Δ weight
- down 0.22 pts
- Value
- ₹115 Cr
- Δ value
- down ₹3.7 Cr
- Status
- Trimmed
- Weight
- 3.01%
- Δ weight
- up 3.01 pts
- Value
- ₹110 Cr
- Δ value
- up ₹110 Cr
- Status
- New
- Weight
- 2.89%
- Δ weight
- up 0.02 pts
- Value
- ₹105 Cr
- Δ value
- up ₹4.4 Cr
- Status
- Added
- Weight
- 2.73%
- Δ weight
- down 0.14 pts
- Value
- ₹99.3 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Weight
- 2.73%
- Δ weight
- up 0.19 pts
- Value
- ₹99.2 Cr
- Δ value
- up ₹10.1 Cr
- Status
- Added
- Weight
- 2.33%
- Δ weight
- up 2.33 pts
- Value
- ₹84.8 Cr
- Δ value
- up ₹84.8 Cr
- Status
- New
- Weight
- 1.96%
- Δ weight
- down 0.25 pts
- Value
- ₹71.2 Cr
- Δ value
- down ₹6.4 Cr
- Status
- Trimmed
- Weight
- 1.94%
- Δ weight
- up 0.13 pts
- Value
- ₹70.6 Cr
- Δ value
- up ₹7 Cr
- Status
- Added
- Weight
- 1.74%
- Δ weight
- down 0.27 pts
- Value
- ₹63.2 Cr
- Δ value
- down ₹7.4 Cr
- Status
- Trimmed
- Weight
- 1.59%
- Δ weight
- up 0.13 pts
- Value
- ₹57.7 Cr
- Δ value
- up ₹6.5 Cr
- Status
- Added
- Weight
- 1.33%
- Δ weight
- down 0.06 pts
- Value
- ₹48.2 Cr
- Δ value
- down ₹44 L
- Status
- Trimmed
- Weight
- 1.19%
- Δ weight
- down 0.03 pts
- Value
- ₹43.3 Cr
- Δ value
- up ₹27 L
- Status
- Added
- Weight
- 1.08%
- Δ weight
- down 0.12 pts
- Value
- ₹39.2 Cr
- Δ value
- down ₹2.8 Cr
- Status
- Trimmed
- Weight
- 0.99%
- Δ weight
- up 0.07 pts
- Value
- ₹36 Cr
- Δ value
- up ₹3.8 Cr
- Status
- Added
- Weight
- 0.88%
- Δ weight
- up 0.10 pts
- Value
- ₹31.9 Cr
- Δ value
- up ₹4.7 Cr
- Status
- Added
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.87%
- Δ weight
- down 0.07 pts
- Value
- ₹31.6 Cr
- Δ value
- down ₹1.3 Cr
- Status
- Trimmed
- Weight
- 0.84%
- Δ weight
- up 0.84 pts
- Value
- ₹30.6 Cr
- Δ value
- up ₹30.6 Cr
- Status
- New
- Weight
- 0.47%
- Δ weight
- up 0.09 pts
- Value
- ₹17.1 Cr
- Δ value
- up ₹3.8 Cr
- Status
- Added
- Weight
- 0.16%
- Δ weight
- down 0.02 pts
- Value
- ₹6 Cr
- Δ value
- down ₹35 L
- Status
- Trimmed
- Weight
- 0.16%
- Δ weight
- down <0.01 pts
- Value
- ₹5.7 Cr
- Δ value
- up ₹7 L
- Status
- Added
What changed, Jun 2026 to Jul 2026
New New positions (3)
- Manipal Health Enterprises Ltd3.0% · ₹110 Cr
- Divi's Laboratories Limited2.3% · ₹84.8 Cr
- Eris Lifesciences Limited0.8% · ₹30.6 Cr
Exited Exited (2)
- Illumina Incwas 7.6% · ₹267 Cr
- Emcure Pharmaceuticals Limitedwas 0.4% · ₹12.8 Cr
Added Biggest additions
- Alkem Laboratories Limitedup ₹77.2 Cr (+2.03% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jun 2026, the weight rose most in Pharmaceuticals & Biotechnology (+4.9 pts), and fell most in Healthcare Services (−4.2 pts) and Healthcare Equipment & Supplies (−0.5 pts).
- Pharmaceuticals & Biotechnology61.5% → 66.4%+4.9 pts
- Healthcare Services23.9% → 19.6%−4.2 pts
- Healthcare Equipment & Supplies8.6% → 8.1%−0.5 pts
- Insurance1.3% → 1.2%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jul 2023 | Jul 2025 | Jan 2026 | Apr 2026 | Jun 2026 | Jul 2026 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 72.4% | 67.5% | 62.5% | 63.9% | 61.5% | 66.4% |
| Healthcare Services | 12.8% | 17.4% | 20.0% | 19.4% | 23.9% | 19.6% |
| Healthcare Equipment & Supplies | 5.7% | 6.9% | 10.9% | 10.5% | 8.6% | 8.1% |
| Pharmaceuticals | 5.6% | 6.1% | 4.6% | 4.2% | 4.8% | 4.8% |
| Insurance | 2.3% | 1.5% | 1.5% | 1.4% | 1.3% | 1.2% |
Allocation in Jul 2026change vs Jun 2026
- Pharmaceuticals & Biotechnology (14)66.4%▲ 4.9 pts
- Healthcare Services (8)19.6%▼ 4.2 pts
- Healthcare Equipment & Supplies (3)8.1%▼ 0.5 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Jul 2026
6.7%
unchanged vs Jun 2026
- Cash alone
- 6.5%
- cash and net receivables
- A year earlier
- 1.8%
- Jul 2025 · now ▲ 4.9 pts
- Last 12 months
- 1.0% – 6.8%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.